FDA Brief

Warning letters Drugs

FDA warning letter to

Thea Pharma, Inc.

High riskIssued Jul 9, 2025Posted Jul 15, 2025Center for Drug Evaluation and Research (CDER)

FDA warns Thea Pharma that IVIZIA OTC lubricant eye drops are an unapproved and misbranded new drug.

What happened

On August 29, 2024, FDA reviewed IVIZIA labeling on ivizia.com and an Amazon storefront where the eye drops were sold without a prescription. FDA found claims that made the product intended as an ophthalmic demulcent drug and found the product did not meet OTC monograph M018. FDA also found no approved application, so it called the product an unapproved new drug and misbranded.

What FDA found

  1. The IVIZIA eye drops are an unapproved new drug because no FDA-approved application is in effect and the product does not meet the OTC monograph for ophthalmic demulcents.

    FD&C Act sections 505(a) and 301(d), 21 U.S.C. 355(a) and 331(d); OTC monograph M018
  2. The product is misbranded because it is a nonprescription drug subject to section 505G but does not comply with that section and has no approved application.

    FD&C Act section 502(ee), 21 U.S.C. 352(ee)
  3. Hyaluronic acid and trehalose are not permitted active ingredients for OTC ophthalmic demulcent drug products under M018.

    OTC monograph M018; FD&C Act section 505G, 21 U.S.C. 355h
  4. Website claims make hyaluronic acid and trehalose active ingredients even though the label lists them as inactive.

    21 CFR 201.66(b)(2)

What FDA wants

FDA asks Thea Pharma to respond in writing within fifteen working days describing corrective steps, how it will prevent recurrence, and related documentation. If it cannot finish, it must explain why and give a completion date.

Who should pay attention

  • OTC eye drop brands and marketers
  • contract manufacturers of ophthalmic demulcent products
  • online retailers and distributors selling OTC eye care products

This is a summary. Read the original letter on fda.gov.

Thea Pharma, Inc.'s FDA history

Recalls in the last 12 months

May 6 Class II Thea Pharma, Inc.
Drug
Similasan, iVIZIA, Sterile Lubricant Eye Drops (Povidone 0.5%), 0.33 Fl oz (10 mL), Made in France, Distributed by: Thea Pharma Inc., Waltham, MA 02451, NDC 59262-700-11
Lack of Assurance of Sterility: This recall has been initiated due to CGMP deviations found by the FDA during an inspection of the manufacturer.
May 6 Class II Thea Pharma, Inc.
Drug
iVIZIA, Sterile Lubricant Eye Drops (Povidone 0.5%), 0.33 Fl oz (10 mL), Made in France, Distributed by: Thea Pharma Inc., Waltham, MA 02451, NDC 82584-700-11
Lack of Assurance of Sterility: This recall has been initiated due to CGMP deviations found by the FDA during an inspection of the manufacturer.

Full company page

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Bella’s Nutri Shop Inc.

    Bella’s Nutri Shop sells “Tawon Liar” as an unapproved drug with hidden dexamethasone, tapentadol, and meloxicam.

    High risk
  4. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk